Source: EIN Presswire

Press Release: Imstem : ImStem Biotechnology to present at 2022 Cell & Gene Meeting On the MESA

FARMINGTON, CT, USA, September 6, 2022 /⁨EINPresswire.com⁩/ -- ImStem Biotechnology, Inc., a clinical stage biotechnology company focused on stem cell based regenerative cellular therapies to treat serious diseases with unmet need, announced today that it ...

Read full article »

Imstem's Competitors | Imstem's News | Imstem's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Rami Levin

CEO Approval Rating

90/100

Imstem is a Connecticut-based biotechnology company that develops and commercializes stem cell based regenerative cellular therapies for the treatment of serious diseases.